INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2013

Evidence supports maintaining 25OHD levels above 20 ng/mL, making recommendations for 30 ng/mL or higher premature.

Authors analyzed published randomized controlled clinical trials to define optimal vitamin D intake and status for bone and extraskeletal health. Apart from reducing falls in the elderly with 800 IU/d of vitamin D3, extraskeletal causality remains unproven in RCTs, though the greatest risk for cancer, infections, cardiovascular, and metabolic diseases associates with 25OHD levels below 20 ng/mL. RCT evidence indicates calcium and bone homeostasis normalizes with 25OHD levels above 20 ng/mL, and 800 IU/d with calcium reduces fracture incidence by about 20%. The authors concluded that a daily intake of 500-700 IU is sufficient to maintain 20 ng/mL, making recommendations for 1500-2000 IU/d or serum levels of 30 ng/mL or higher premature.

Study type
Critical narrative review of published RCTs
Who was studied
Adults, elderly subjects, and postmenopausal women
What was measured
Bone and extraskeletal health outcomes, serum 25OHD levels, falls, and fractures

THE PAPER

Optimal vitamin D status: a critical analysis on the basis of evidence-based medicine.

Bouillon R, Van Schoor NM, Gielen E, Boonen S, Mathieu C, Vanderschueren D, Lips P. J Clin Endocrinol Metab, 2013.

PubMed 23922354 ↗DOI 10.1210/jc.2013-1195 ↗

Heart & arteriesCancerNutrients & adequacyHealthy aging & longevityBones & muscles

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.